FDA hands down par­tial hold for Sun Phar­ma's alope­cia JAK can­di­date

The FDA has no­ti­fied Sun Phar­ma that the IND for its new­ly-ac­quired alope­cia can­di­date is un­der par­tial clin­i­cal hold af­ter a pa­tient ex­pe­ri­enced a blood …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER